共 31 个 OTC 专论产品
| 序号 | NDC编码 | 商品名 | 剂型 | 上市日期 | 专论编号 |
|---|---|---|---|---|---|
| 1 | 55758-319-04 | Rapidol Sodium Bicarbonate | POWDER | 2020-11-23 | M001 |
| 2 | 55758-374-02 | El Valle Decolorized Iodine | TINCTURE | 2023-05-31 | M004 |
| 3 | 55758-373-01 | El Valle Gentian Violet | LIQUID | 2023-05-31 | M004 |
| 4 | 55758-375-02 | El Valle Merthiolate | LIQUID | 2023-05-31 | M004 |
| 5 | 55758-440-03 | Rapidol Triple Antibiotic | OINTMENT | 2024-11-04 | M004 |
| 6 | 55758-102-03 | Cura Hongo Antifungal | CREAM | 2022-05-31 | M005 |
| 7 | 55758-418-10 | Dr. Fibra | POWDER | 2024-06-30 | M007 |
| 8 | 55758-419-03 | Rapidol Sal Inglesa | CRYSTAL | 2024-08-01 | M007 |
| 9 | 55758-504-01 | Laxomil | TABLET, COATED | 2025-07-10 | M007 |
| 10 | 55758-331-07 | Rapidol Stomach Relief | LIQUID | 2022-12-08 | M008 |
| 11 | 55758-013-04 | SanaTos Children Cough and Congestion Cherry | LIQUID | 2016-01-01 | M012 |
| 12 | 55758-012-05 | Vitapirena | GRANULE, FOR SOLUTION | 2023-10-25 | M013 |
| 13 | 55758-026-04 | Dolex Children Pain and Fever | SUSPENSION | 2023-01-01 | M013 |
| 14 | 55758-056-25 | Sanatos Nighttime Multi Symptoms | LIQUID | 2014-12-01 | M013 |
| 15 | 55758-055-25 | Sanatos Multi Symptom Daytime | LIQUID | 2014-12-01 | M013 |
| 16 | 55758-311-06 | SanaTos X | LIQUID | 2018-12-03 | M013 |
| 17 | 55758-326-25 | Dolex Fem | TABLET, COATED | 2020-10-01 | M013 |
| 18 | 55758-363-60 | Rapidol Aspirin | TABLET, COATED | 2023-08-01 | M013 |
| 19 | 55758-415-06 | Sanatos Multi Symptom Daytime | LIQUID | 2023-12-01 | M013 |
| 20 | 55758-416-06 | Sanatos Multi Symptoms Nighttime | LIQUID | 2023-12-01 | M013 |
| 21 | 55758-435-24 | DoloDent Toothache For adults | TABLET | 2024-07-30 | M013 |
| 22 | 55758-439-01 | Rapidol 500 Extra Strength | TABLET | 2024-08-01 | M013 |
| 23 | 55758-503-24 | Rapidol | CAPSULE, COATED | 2025-07-17 | M013 |
| 24 | 55758-509-24 | Dolex Forte | TABLET | 2025-08-12 | M013 |
| 25 | 55758-506-01 | DoloEar | LIQUID | 2025-05-15 | M014 |
| 26 | 55758-039-01 | Parche Leon | PATCH | 2020-02-28 | M017 |
| 27 | 55758-030-05 | Artridon Glucosamine | OINTMENT | 2024-11-04 | M017 |
| 28 | 55758-511-01 | Redness Relief | SOLUTION/ DROPS | 2026-07-01 | M018 |
| 29 | 55758-505-01 | Dolodent Maximum Strength | LIQUID | 2025-05-14 | M022 |
| 30 | 55758-441-10 | MebendamaX Pinworm | TABLET | 2024-08-01 | M024 |
| 31 | 55758-409-15 | Kingskin | LIQUID | 2021-03-31 | M028 |
标准化流程确保专论判定准确、文件齐备、标签合规,缩短整体办理周期。
提交配方表、活性成分、宣称用途及现有检测报告,进行初步合规评估。
比对21 CFR对应专论条款,确认产品归属类别及GRASE活性成分浓度范围。
指定美国代理人,完成FDA药品生产设施注册与产品列名申请。
按21 CFR 201.66制作Drug Facts标签,核对警示语、适应症与使用方法。
提供完整合规文件包,协助清关申报与上市后持续合规维护。
关于 OTC 化妆品出口美国合规的常见疑问解答。
微信号:KOL123567
添加时请备注「公司-职务-姓名」
优先安排资深法规专家 1 对 1 对接
我们已收到您的合规咨询需求
资深 FDA 法规顾问将在 1 个工作日内与您联系